TwitterFacebook
National investment to produce revolutionary mRNA therapies at UQ
A pilot facility at The University of Queensland could be producing mRNA vaccines and cancer therapies for research and development within months after receiving backing from the Australian Government.
TIA CEO Dr Stuart Newman said that this support would enable the facility to produce high-quality, high-purity nucleic acids – RNA and DNA – to support the work of nucleic acid researchers across the country.
“This investment complements recent investments in later-stage, large-scale mRNA manufacturing, as well as TIA’s own ongoing investment in biologics production to support R&D,” Dr Newman said.